https://www.selleckchem.com/pr....oducts/fasoracetam-n
Background aims Several methods to expand and activate (EA) NK cells ex vivo have been developed for the treatment of relapsed or refractory cancers. Infusion of fresh NK cells is generally preferred to the infusion of cryopreserved/thawed (C/T) NK cells because of concern that cryopreservation diminishes NK cell activity. However, there has been little head-to-head comparison of the functionality of fresh versus C/T NK cell products. Methods We evaluated activity of fresh and C/T EA NK cells generated by interleukin (IL)-15,
Like
Comment
Share
